AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

Sanofi and Regeneron’s dupilumab for asthma. The partners have unveiled Phase IIa data at the American Thoracic Society meeting in Philadelphia on dupilumab, an interleukin 4 receptor which modulates signalling of both the IL-4 and IL-13 proteins, which are linked to inflammation

 Uncategorized  Comments Off on Sanofi and Regeneron’s dupilumab for asthma. The partners have unveiled Phase IIa data at the American Thoracic Society meeting in Philadelphia on dupilumab, an interleukin 4 receptor which modulates signalling of both the IL-4 and IL-13 proteins, which are linked to inflammation
May 232013
 

read all

http://newdrugapprovals.wordpress.com/2013/05/23/sanofi-and-regeneron-looksanofi-and-regenerons-dupilumab-for-asthma-the-partners-have-unveiled-phase-iia-data-at-the-american-thoracic-society-meeting-in-philadelphia-on-dupilumab-an-interleukin/

Share

Capsaicin-Generic Licensing News

 Uncategorized  Comments Off on Capsaicin-Generic Licensing News
May 222013
 
 

http://www.leadformix.com/ef1/preview_campaign.php?lf1=272463197a140512625317b6973550

 

  
CAPSAICIN
Capsaicin is an ingredient in topical skin preparations used to relieve pain. Capsaicin works by depleting or interfering with substance P, a chemical involved in transmitting pain impulses to the brain.The properties of capsaicin make it an option for relieving pain associated with osteoarthritis, rheumatoid arthritis, and diabetic neuropathy. Capsaicin is used to relieve muscle pain, joint pain, or nerve pain.

Click here to contact Logenex about this product.
Share
 Older Entries  Newer Entries
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: